<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://hdl.handle.net/10171/18871" />
  <subtitle />
  <id>http://hdl.handle.net/10171/18871</id>
  <updated>2013-06-19T04:17:05Z</updated>
  <dc:date>2013-06-19T04:17:05Z</dc:date>
  <entry>
    <title>Influencia del sexo sobre la indicación de revascularización coronaria quirúrgica. Peculiaridades técnicas y resultados en la mujer</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/29275" />
    <author>
      <name>Llorens, R. (Rafael)</name>
    </author>
    <id>http://hdl.handle.net/10171/29275</id>
    <updated>2013-06-05T01:39:50Z</updated>
    <published>1993-12-31T23:00:00Z</published>
    <summary type="text">Title: Influencia del sexo sobre la indicación de revascularización coronaria quirúrgica. Peculiaridades técnicas y resultados en la mujer
Author(s) : Llorens, R. (Rafael)</summary>
    <dc:date>1993-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Normas de actuación en el paciente con infarto agudo de miocardio</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/29274" />
    <author>
      <name>Alegria, E. (Eduardo)</name>
    </author>
    <author>
      <name>Lopez-Bescos, L. (L.)</name>
    </author>
    <author>
      <name>Asin, E. (E.)</name>
    </author>
    <author>
      <name>Cabades, A. (A.)</name>
    </author>
    <author>
      <name>San-Jose, J.M. (J. M.)</name>
    </author>
    <id>http://hdl.handle.net/10171/29274</id>
    <updated>2013-06-05T01:38:51Z</updated>
    <published>1993-12-31T23:00:00Z</published>
    <summary type="text">Title: Normas de actuación en el paciente con infarto agudo de miocardio
Author(s) : Alegria, E. (Eduardo); Lopez-Bescos, L. (L.); Asin, E. (E.); Cabades, A. (A.); San-Jose, J.M. (J. M.)</summary>
    <dc:date>1993-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Aneurisma de aorta ascendente en pacientes con sustitución valvular aórtica previa</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/29273" />
    <author>
      <name>Gonzalez-Fernandez, A.L. (A. L.)</name>
    </author>
    <author>
      <name>Martin-Trenor, A. (Alejandro)</name>
    </author>
    <author>
      <name>Herreros, J. (Jesús)</name>
    </author>
    <author>
      <name>Llorens, R. (Rafael)</name>
    </author>
    <author>
      <name>Gil, O. (O.)</name>
    </author>
    <author>
      <name>Calabuig, J. (José)</name>
    </author>
    <author>
      <name>Alava, E. (Enrique) de</name>
    </author>
    <id>http://hdl.handle.net/10171/29273</id>
    <updated>2013-06-05T01:35:47Z</updated>
    <published>1992-12-31T23:00:00Z</published>
    <summary type="text">Title: Aneurisma de aorta ascendente en pacientes con sustitución valvular aórtica previa
Author(s) : Gonzalez-Fernandez, A.L. (A. L.); Martin-Trenor, A. (Alejandro); Herreros, J. (Jesús); Llorens, R. (Rafael); Gil, O. (O.); Calabuig, J. (José); Alava, E. (Enrique) de
Abstract: We conclude that an aggressive surgical approach should be adopted in patients with degenerative aortic regurgitation and moderate dilatation of the ascending aorta because of the rapid progression of the aortic disease. We advise complete replacement of the aortic root.</summary>
    <dc:date>1992-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Endocarditis por Listeria monocytogenes sobre bioprótesis de Hancock</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/29272" />
    <author>
      <name>Aparici, M. (M.)</name>
    </author>
    <author>
      <name>Saenz-de-Buruaga, J.D. (J. D.)</name>
    </author>
    <author>
      <name>Castello, R. (R.)</name>
    </author>
    <author>
      <name>Hidalgo, R. (R.)</name>
    </author>
    <author>
      <name>Peteiro, J. (J.)</name>
    </author>
    <author>
      <name>Frades, M. (M.)</name>
    </author>
    <author>
      <name>Martin-Trenor, A. (Alejandro)</name>
    </author>
    <id>http://hdl.handle.net/10171/29272</id>
    <updated>2013-06-05T01:35:46Z</updated>
    <published>1987-12-31T23:00:00Z</published>
    <summary type="text">Title: Endocarditis por Listeria monocytogenes sobre bioprótesis de Hancock
Author(s) : Aparici, M. (M.); Saenz-de-Buruaga, J.D. (J. D.); Castello, R. (R.); Hidalgo, R. (R.); Peteiro, J. (J.); Frades, M. (M.); Martin-Trenor, A. (Alejandro)</summary>
    <dc:date>1987-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Xenoinjerto de Carpentier-Edwards: evolución a los 13 años</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/29270" />
    <author>
      <name>Casillas, J.A. (J. A.)</name>
    </author>
    <author>
      <name>Llorens, R. (Rafael)</name>
    </author>
    <author>
      <name>Herreros, J. (Jesús)</name>
    </author>
    <author>
      <name>Martin-Trenor, A. (Alejandro)</name>
    </author>
    <author>
      <name>Arcas, R. (R.)</name>
    </author>
    <id>http://hdl.handle.net/10171/29270</id>
    <updated>2013-06-05T01:37:07Z</updated>
    <published>1984-12-31T23:00:00Z</published>
    <summary type="text">Title: Xenoinjerto de Carpentier-Edwards: evolución a los 13 años
Author(s) : Casillas, J.A. (J. A.); Llorens, R. (Rafael); Herreros, J. (Jesús); Martin-Trenor, A. (Alejandro); Arcas, R. (R.)</summary>
    <dc:date>1984-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Clonidina en el tratamiento de la deshabituación tabáquica. Comparación con chicles de nicotina</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/29256" />
    <author>
      <name>Aparici, M. (M.)</name>
    </author>
    <author>
      <name>Fernandez-Gonzalez, A.L. (Ángel L.)</name>
    </author>
    <author>
      <name>Alegria, E. (Eduardo)</name>
    </author>
    <id>http://hdl.handle.net/10171/29256</id>
    <updated>2013-06-04T09:58:47Z</updated>
    <published>1993-12-31T23:00:00Z</published>
    <summary type="text">Title: Clonidina en el tratamiento de la deshabituación tabáquica. Comparación con chicles de nicotina
Author(s) : Aparici, M. (M.); Fernandez-Gonzalez, A.L. (Ángel L.); Alegria, E. (Eduardo)
Abstract: The objective of our work was to carry out a prospective study on the effectiveness of clonidine and nicotine gum in the treatment of tobacco withdrawal. Sixty smokers were randomly distributed in two groups and were included in a tobacco withdrawal program. One group received oral clonidine treatment while the other group was given nicotine gum. Adjuvant therapy such as group therapy or psychotherapy was not performed. At the end of one year there were no significant differences between the two groups with regards to the number of subjects who have continued to stop smoking. There were also no significant differences between the two groups with regards to the symptoms of tobacco abstinence. When we studied the relation between treatment fulfillment and tobacco withdrawal we observed that the clonidine treated group had a significantly greater number of success compared to the nicotine group (p &lt; 0.01).</summary>
    <dc:date>1993-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Fijación activa y perforación ventricular: ¿una nueva entidad?</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/27511" />
    <author>
      <name>Rodriguez-Mañero, M. (Moisés)</name>
    </author>
    <author>
      <name>Bastarrika, G. (Gorka)</name>
    </author>
    <author>
      <name>Macias, A. (Alfonso)</name>
    </author>
    <id>http://hdl.handle.net/10171/27511</id>
    <updated>2012-12-21T01:08:10Z</updated>
    <published>2010-12-31T23:00:00Z</published>
    <summary type="text">Title: Fijación activa y perforación ventricular: ¿una nueva entidad?
Author(s) : Rodriguez-Mañero, M. (Moisés); Bastarrika, G. (Gorka); Macias, A. (Alfonso)
Abstract: First, a new active fixation lead was implanted in the interventricular septum; the old lead was then extracted with a Cook stylet. The&#xD;
patient’s clinical course was satisfactory and there were no procedure-related complications.&#xD;
In conclusion, within the battery of diagnostic tests available to investigate suspected cardiac perforation, computed angiotomography&#xD;
of the chest is a highly useful complementary technique for the management of this complication.</summary>
    <dc:date>2010-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Neurohormonas y citocinas en la insuficiencia cardíaca. Correlación con la reserva de flujo coronario</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/23496" />
    <author>
      <name>Coma-Canella, I. (Isabel)</name>
    </author>
    <author>
      <name>Macias, A. (Alfonso)</name>
    </author>
    <author>
      <name>Varo, N. (Nerea)</name>
    </author>
    <author>
      <name>Sanchez-Ibarrola, A. (Alfonso)</name>
    </author>
    <id>http://hdl.handle.net/10171/23496</id>
    <updated>2012-10-27T00:07:14Z</updated>
    <published>2004-12-31T23:00:00Z</published>
    <summary type="text">Title: Neurohormonas y citocinas en la insuficiencia cardíaca. Correlación con la reserva de flujo coronario
Author(s) : Coma-Canella, I. (Isabel); Macias, A. (Alfonso); Varo, N. (Nerea); Sanchez-Ibarrola, A. (Alfonso)
Abstract: Introduction and objectives. In heart failure, the coronary&#xD;
flow reserve (CFR) measured by positron-emission&#xD;
tomography (PET) is reduced. As neurohormone and cytokine&#xD;
levels are also altered in patients with the condition,&#xD;
our aim was to determine whether there is a correlation&#xD;
between CFR and neurohormone and cytokine&#xD;
levels.&#xD;
Patients and method. The study included 40 patients&#xD;
with heart failure but without ischemic heart disease. Myocardial&#xD;
blood flow was measured by PET using nitrogen-&#xD;
13 ammonia at baseline and during ATP infusion. The&#xD;
CFR was calculated for each patient. In addition, levels of&#xD;
the following were determined: norepinephrine, endothelin-&#xD;
1, angiotensin-II, atrial natriuretic peptide (ANP), brain&#xD;
natriuretic peptide (BNP), tumor necrosis factor-alpha, interleukin&#xD;
(IL)-1β, soluble IL-2 receptor, and IL-6.&#xD;
Results. All neurohormone levels were elevated above&#xD;
reference values. The levels of all cytokines, except IL-1β,&#xD;
were also elevated. There was a significant negative correlation&#xD;
between CFR and the levels of several neurohormones:&#xD;
ANP (r=–0.476), BNP (r=–0.442), and IL-6&#xD;
(r=–0.509).&#xD;
Conclusions. In heart failure, the decrease in CFR is&#xD;
correlated with increases in the levels of certain neurohormones&#xD;
(i.e., ANP and BNP) and cytokines (i.e., IL-6), with&#xD;
vasodilatory effect. These increases are probably are related&#xD;
to compensatory mechanisms that are unable to correct&#xD;
for the endothelial dysfunction present in these patients.</summary>
    <dc:date>2004-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Técnica de primera elección para la valoración de la viabilidad miocárdica. Gammagrafía cardiaca de perfusión</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/23351" />
    <author>
      <name>Coma-Canella, I. (Isabel)</name>
    </author>
    <id>http://hdl.handle.net/10171/23351</id>
    <updated>2012-10-12T00:10:08Z</updated>
    <published>1997-12-31T23:00:00Z</published>
    <summary type="text">Title: Técnica de primera elección para la valoración de la viabilidad miocárdica. Gammagrafía cardiaca de perfusión
Author(s) : Coma-Canella, I. (Isabel)
Abstract: Stress echocardiography and perfusion scintigraphy&#xD;
are both useful techniques in the assessment&#xD;
of myocardial viability. The use of one technique&#xD;
or the other as the first choice test depends&#xD;
mainly on each hospital’s experience. Perfusion&#xD;
scintigraphy should be chosen as the first technique&#xD;
in the following situations: a) hospitals with&#xD;
little experience in stress echocardiography and a&#xD;
good Nuclear Medicine department; b) patients&#xD;
with a bad acoustic window in rest echocardiography;&#xD;
c) contraindication of a high dobutamine&#xD;
dose, and d) need of quantification of viable area.&#xD;
When having chosen echocardiography as the&#xD;
first technique, perfusion scintigraphy is indicated&#xD;
when the response to dobutamine of the asynergic&#xD;
area does not allow the confirmation or the rejection&#xD;
of the presence of viability.</summary>
    <dc:date>1997-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Tratamiento de la insuficiencia cardíaca avanzada mediante estimulación biventricular. Experiencia inicial en una serie de 22 casos consecutivos</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/23340" />
    <author>
      <name>Garcia-Bolao, I. (Ignacio)</name>
    </author>
    <author>
      <name>Macias, A. (Alfonso)</name>
    </author>
    <author>
      <name>Alegria, E. (Eduardo)</name>
    </author>
    <author>
      <name>Berenguel, A. (Alejandro)</name>
    </author>
    <author>
      <name>Gavira, J.J. (Juan José)</name>
    </author>
    <author>
      <name>Azcarate, P.M. (Pedro María)</name>
    </author>
    <author>
      <name>Barba, J. (Joaquín)</name>
    </author>
    <id>http://hdl.handle.net/10171/23340</id>
    <updated>2012-10-10T00:10:56Z</updated>
    <published>2002-12-31T23:00:00Z</published>
    <summary type="text">Title: Tratamiento de la insuficiencia cardíaca avanzada mediante estimulación biventricular. Experiencia inicial en una serie de 22 casos consecutivos
Author(s) : Garcia-Bolao, I. (Ignacio); Macias, A. (Alfonso); Alegria, E. (Eduardo); Berenguel, A. (Alejandro); Gavira, J.J. (Juan José); Azcarate, P.M. (Pedro María); Barba, J. (Joaquín)
Abstract: Recent data suggest that biventricular pacing may play&#xD;
      an important role in treating advanced heart failure in the presence of a&#xD;
      significant interventricular and/or intraventricular conduction disorder by&#xD;
      correcting cardiac dysynchrony. In this article, we review the initial technical &#xD;
      and clinical experience with cardiac resynchronization therapy in an&#xD;
      electrophysiology laboratory. METHODS: The first 22 consecutive patients with&#xD;
      severe congestive heart failure, ejection fraction &lt; 0.35, NYHA functional class &#xD;
      III or IV, and QRS duration &gt; 120 ms who were implanted biventricular pacemakers &#xD;
      were studied. Clinical, electrocardiographic, and echocardiographic evaluations&#xD;
      were made before and three months after pacemaker implantation. Acute functional &#xD;
      capacity testing with peak oxygen uptake was measured during biventricular pacing&#xD;
      and during intrinsic rhythm or right ventricular pacing three months after the&#xD;
      implantation procedure. RESULTS: The success rate of pacemaker implantation was&#xD;
      95%. Pre-discharge left ventricular pacing was achieved in 91%, with an average&#xD;
      pacing threshold of 1.53 (1.04) volts. NYHA functional class improved (p = 0.039)&#xD;
      from 3.4 (0.7) to 2.3 (0.78). The rate of hospitalization for heart failure&#xD;
      decreased from an average of 3.12 (0.58) three months before the procedure to&#xD;
      1.38 (0.34) three months after the procedure. Peak oxygen uptake was&#xD;
      significantly greater (p = 0.028) during biventricular pacing: 14.89 (2.1)&#xD;
      ml/min/kg, than during intrinsic rhythm or right ventricular pacing: 12.65 (2.3) &#xD;
      ml/min/kg. CONCLUSIONS: Cardiac resynchronization therapy can be performed safely&#xD;
      and with a high success rate in the electrophysiology laboratory. Biventricular&#xD;
      pacing seems to improve the symptoms of congestive heart failure in patients with&#xD;
      evidence of atrioventricular and/or interventricular/intraventricular&#xD;
      dysynchrony. An acute benefit in peak oxygen uptake was associated with&#xD;
      biventricular pacing after the implantation procedure.</summary>
    <dc:date>2002-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Disminución de la reserva de flujo coronario en pacientes con insuficiencia cardíaca no isquémica</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/23333" />
    <author>
      <name>Coma-Canella, I. (Isabel)</name>
    </author>
    <author>
      <name>Garcia-Velloso, M.J. (María José)</name>
    </author>
    <author>
      <name>Macias, A. (Alfonso)</name>
    </author>
    <author>
      <name>Villar, L. (Luis)</name>
    </author>
    <author>
      <name>Cosin, J. (Juan)</name>
    </author>
    <author>
      <name>Marti-Climent, J.M. (Josep M.)</name>
    </author>
    <author>
      <name>Artaiz, M. (Miguel)</name>
    </author>
    <id>http://hdl.handle.net/10171/23333</id>
    <updated>2012-10-10T00:04:53Z</updated>
    <published>2002-12-31T23:00:00Z</published>
    <summary type="text">Title: Disminución de la reserva de flujo coronario en pacientes con insuficiencia cardíaca no isquémica
Author(s) : Coma-Canella, I. (Isabel); Garcia-Velloso, M.J. (María José); Macias, A. (Alfonso); Villar, L. (Luis); Cosin, J. (Juan); Marti-Climent, J.M. (Josep M.); Artaiz, M. (Miguel)
Abstract: Introduction and objectives. Coronary flow reserve&#xD;
(CFR) is impaired not only in ischemic heart disease, but&#xD;
also in cardiac diseases that may or may not course with&#xD;
heart failure. The aim of the present study was to determine&#xD;
if the severity of heart failure can influence CFR impairment.&#xD;
Methods. Forty patients with non-ischemic heart disease&#xD;
and heart failure were studied 41 times. Four groups&#xD;
were established: 1. 10 patients in functional class III-IV;&#xD;
2. 10 patients in functional class II not taking beta-blockers;&#xD;
3. 11 patients in class II treated with carvedilol, and 4.&#xD;
10 patients in class I. These patients had a history of heart&#xD;
failure and systolic dysfunction. Myocardial blood flow&#xD;
(MBF) was measured with positron emission tomography&#xD;
(PET) and N-13 ammonia at rest (r) and during adenosine&#xD;
triphosphate (ATP) infusion.&#xD;
Results. MBF and CFR were significantly higher in&#xD;
group 4 (1.95 ± 0.58 and 2.40 ± 0.95 ml/min/g) than in&#xD;
group 1 (1.02 ± 0.52 and 1.46 ± 0.48 ml/min/g). CFR tended&#xD;
to be higher in groups 2 (1.73 ± 0.72), and 3 (1.89 ±&#xD;
0.75) vs group 1. No significant correlation was found between&#xD;
CFR and the following variables: age, systolic blood&#xD;
pressure, ventricular mass index, ventricular volume indexes,&#xD;
and ejection fraction.&#xD;
Conclusions. Coronary microvascular function is impaired&#xD;
in non-ischemic heart failure, and the impairment is&#xD;
related to functional class, regardless of the underlying&#xD;
responsible heart disease.</summary>
    <dc:date>2002-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Hematoma pericárdico dos años después de cirugía coronaria</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/23272" />
    <author>
      <name>Garcia-Fuster, R. (Rafael)</name>
    </author>
    <author>
      <name>Llorens, R. (Rafael)</name>
    </author>
    <author>
      <name>Melero, J.M. (José María)</name>
    </author>
    <author>
      <name>Barba, J. (Joaquín)</name>
    </author>
    <author>
      <name>Stefano, S. (Salvatore) di</name>
    </author>
    <author>
      <name>Legarra, J.J. (Juan José)</name>
    </author>
    <author>
      <name>Alegria, E. (Eduardo)</name>
    </author>
    <id>http://hdl.handle.net/10171/23272</id>
    <updated>2012-10-03T00:04:20Z</updated>
    <published>1996-12-31T23:00:00Z</published>
    <summary type="text">Title: Hematoma pericárdico dos años después de cirugía coronaria
Author(s) : Garcia-Fuster, R. (Rafael); Llorens, R. (Rafael); Melero, J.M. (José María); Barba, J. (Joaquín); Stefano, S. (Salvatore) di; Legarra, J.J. (Juan José); Alegria, E. (Eduardo)
Abstract: Cardiac tamponade is a life-threatening complication&#xD;
after cardiac surgery which may develop in&#xD;
the early or late postoperative period. The latest&#xD;
have been defined arbitrarily as the ones ocurring&#xD;
after the 7th postoperative day. They are less common&#xD;
than the early ones and most of the cases have&#xD;
been reported up to six months after the operation.&#xD;
They usually determine diagnostic difficulties&#xD;
that can negatively influence the prognosis.&#xD;
Because of its atypical late appearance, a case of&#xD;
a 65 year old man is presented who developed a&#xD;
postpericardiotomy syndrome and subsequently&#xD;
a pericardial clot nearly two years after aortocoronary&#xD;
bypass grafting.</summary>
    <dc:date>1996-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/23253" />
    <author>
      <name>Torres, L. (Luis)</name>
    </author>
    <author>
      <name>Garcia-Trevijano, E.R. (Elena R.)</name>
    </author>
    <author>
      <name>Rodriguez, J.A. (José A.)</name>
    </author>
    <author>
      <name>Carretero, M.V. (M. Victoria)</name>
    </author>
    <author>
      <name>Bustos, M. (Matilde)</name>
    </author>
    <author>
      <name>Fernandez, E. (Estefanía)</name>
    </author>
    <author>
      <name>Eguinoa, E. (Ezequiel)</name>
    </author>
    <author>
      <name>Mato, J.M. (José María)</name>
    </author>
    <author>
      <name>Avila, M.A. (Matías Antonio)</name>
    </author>
    <id>http://hdl.handle.net/10171/23253</id>
    <updated>2012-09-30T00:09:05Z</updated>
    <published>1998-12-31T23:00:00Z</published>
    <summary type="text">Title: Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis
Author(s) : Torres, L. (Luis); Garcia-Trevijano, E.R. (Elena R.); Rodriguez, J.A. (José A.); Carretero, M.V. (M. Victoria); Bustos, M. (Matilde); Fernandez, E. (Estefanía); Eguinoa, E. (Ezequiel); Mato, J.M. (José María); Avila, M.A. (Matías Antonio)
Abstract: Elevated plasma levels of homocysteine have been shown to interfere with normal cell function in a variety of tissues and organs, such as the vascular wall and the liver. However, the molecular mechanisms behind homocysteine effects are not completely understood. In order to better characterize the cellular effects of homocysteine, we have searched for changes in gene expression induced by this amino acid. Our results show that homocysteine is able to induce the expression and synthesis of the tissue inhibitor of metalloproteinases-1 (TIMP-1) in a variety of cell types ranging from vascular smooth muscle cells to hepatocytes, HepG2 cells and hepatic stellate cells. In this latter cell type, homocysteine also stimulated alpha 1(I) procollagen mRNA expression. TIMP-1 induction by homocysteine appears to be mediated by its thiol group. Additionally, we demonstrate that homocysteine is able to promote activating protein-1 (AP-1) binding activity, which has been shown to be critical for TIMP-1 induction. Our findings suggest that homocysteine may alter extracellular matrix homeostasis on diverse tissular backgrounds besides the vascular wall. The liver could be considered as another target for such action of homocysteine. Consequently, the elevated plasma levels of this amino acid found in different pathological or nutritional circumstances may cooperate with other agents, such as ethanol, in the onset of liver fibrosis.</summary>
    <dc:date>1998-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Apoptosis en la cardiopatía hipertensiva</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/23248" />
    <author>
      <name>Diez, J. (Javier)</name>
    </author>
    <author>
      <name>Fortuño, M.A. (María Antonia)</name>
    </author>
    <author>
      <name>Ravassa, S. (Susana)</name>
    </author>
    <id>http://hdl.handle.net/10171/23248</id>
    <updated>2012-09-28T07:16:51Z</updated>
    <published>1998-12-31T23:00:00Z</published>
    <summary type="text">Title: Apoptosis en la cardiopatía hipertensiva
Author(s) : Diez, J. (Javier); Fortuño, M.A. (María Antonia); Ravassa, S. (Susana)</summary>
    <dc:date>1998-12-31T23:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Respuestas del miocardio al estrés biomecánico</title>
    <link rel="alternate" href="http://hdl.handle.net/10171/23058" />
    <author>
      <name>Diez, J. (Javier)</name>
    </author>
    <author>
      <name>Lopez, B. (Begoña)</name>
    </author>
    <author>
      <name>Gonzalez, A. (Arantxa)</name>
    </author>
    <author>
      <name>Ardanaz, N. (Noelia)</name>
    </author>
    <author>
      <name>Fortuño, M.A. (María Antonia)</name>
    </author>
    <id>http://hdl.handle.net/10171/23058</id>
    <updated>2012-08-17T00:09:05Z</updated>
    <published>2000-12-31T23:00:00Z</published>
    <summary type="text">Title: Respuestas del miocardio al estrés biomecánico
Author(s) : Diez, J. (Javier); Lopez, B. (Begoña); Gonzalez, A. (Arantxa); Ardanaz, N. (Noelia); Fortuño, M.A. (María Antonia)
Abstract: El estrés biomecánico del miocardio hace referencia a la situación que se genera cuando, debido a la hipertensión, la hipoxia u otras formas de daño miocárdico, están aumentadas las demandas de trabajo cardíaco y/o se ha perdido miocardio funcionante. Como consecuencia del estrés biomecánico se producen diversas respuestas que afectan a todas las células miocárdicas, en particular a los cardiomiocitos. El resultado final de las mismas son distintas modificaciones fenotípicas que inicialmente son compensadoras (p. ej., hipertrofia), pero que si persiste el estrés pueden mediar la transición de la hipertrofia a la insuficiencia cardíaca (p. ej., apoptosis y fibrosis). Esta revisión se centra en la descripción de las distintas fases de las respuestas miocárdicas al estrés, así como en la consideración de los hallazgos más recientes sobre los mecanismos moleculares implicados en el desarrollo de insuficiencia cardíaca.</summary>
    <dc:date>2000-12-31T23:00:00Z</dc:date>
  </entry>
</feed>

